{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/mrsa-in-primary-care/goals-outcome-measures/nice-quality-standards/","result":{"pageContext":{"chapter":{"id":"e5c4d5c6-ed37-5a97-a1ef-874a072dd190","slug":"nice-quality-standards","fullItemName":"NICE quality standards","depth":2,"htmlHeader":"<!-- begin field 486ca1bb-779e-41f6-8fe9-e66072f97e0e --><h2>NICE quality standards</h2><!-- end field 486ca1bb-779e-41f6-8fe9-e66072f97e0e -->","summary":null,"htmlStringContent":"<!-- begin item 68c93b4a-aa35-45fc-b2c5-9a76ab4866d4 --><!-- begin field ea3fea52-2afa-4bf0-9d85-95223b279dea --><p>The following are included in the National Institute for Health and Care Excellence (NICE) Quality Standards on <a href=\"https://www.nice.org.uk/guidance/qs61\" target=\"_blank\" data-hyperlink-id=\"6690a353-8dbe-48a0-9474-a983008cac6d\">Infection prevention and control (QS61)</a> and <a href=\"https://www.nice.org.uk/guidance/qs113\" target=\"_blank\" data-hyperlink-id=\"8f75f142-1043-4c34-9243-a983008cac95\">Healthcare-associated infections (QS113)</a>.</p><ul><li><strong>NICE quality standards on infection prevention and control (QS61)</strong><ul><li><strong>Statement 1.</strong> People are prescribed antibiotics in accordance with local antibiotic formularies as part of antimicrobial stewardship.</li><li><strong>Statement 2. </strong>Organisations that provide healthcare have a strategy for continuous improvement in infection prevention and control, including accountable leadership, multi-agency working and the use of surveillance systems.</li><li><strong>Statement 3.</strong> People receive healthcare from healthcare workers who decontaminate their hands immediately before and after every episode of direct contact or care.</li><li><strong>Statement 4.</strong> People who need a urinary catheter have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the catheter and its removal as soon as it is no longer needed.</li><li><strong>Statement 5.</strong> People who need a vascular access device have their risk of infection minimised by the completion of specified procedures necessary for the safe insertion and maintenance of the device and its removal as soon as it is no longer needed.</li><li><strong>Statement 6.</strong> People with a urinary catheter, vascular access device or enteral feeding tube, and their family members or carers (as appropriate), are educated about the safe management of the device or equipment, including techniques to prevent infection.</li></ul></li></ul><ul><li><strong>NICE quality standards on healthcare-associated infections (QS113)</strong><ul><li><strong>Statement 1.</strong> Hospitals monitor healthcare-associated infections and other infections of local relevance to drive continuous quality improvement.</li><li><strong>Statement 2.</strong> Hospitals work with local health and social care organisations to assess and manage the risk of infections in hospitals from community outbreaks and incidents.</li><li><strong>Statement 3.</strong> Hospital staff have individual objectives and appraisals on infection prevention and control linked to board-level objectives and strategies.</li><li><strong>Statement 4.</strong> Hospitals involve infection prevention and control teams in the building, refurbishment and maintenance of hospital facilities.</li><li><strong>Statement 5.</strong> People admitted to, discharged from, or transferred between or within hospitals have information about any infections and associated treatments shared with health and social care staff to inform their care.</li></ul></li></ul><!-- end field ea3fea52-2afa-4bf0-9d85-95223b279dea --><!-- end item 68c93b4a-aa35-45fc-b2c5-9a76ab4866d4 -->","topic":{"id":"26f48611-f890-5112-aa26-bef13e5623e1","topicId":"c9e197be-4f79-4d67-bf67-2b2a8a137e03","topicName":"MRSA in primary care","slug":"mrsa-in-primary-care","lastRevised":"Last revised in October 2018","chapters":[{"id":"ba15ac05-528a-5474-8925-89cfea95b961","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"97d099f9-1263-51e7-8c71-fb82256182d3","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f6df2380-e42f-563b-8f75-a588376e1da7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"530a7f74-53c2-5e4e-8c1d-ceb01bccf776","slug":"changes","fullItemName":"Changes"},{"id":"a17267d5-eb08-5126-9312-b78fee4494a2","slug":"update","fullItemName":"Update"}]},{"id":"9537a389-c41a-5355-ac9c-9c56bba48a35","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"124fbaa7-2678-5958-b4be-d5f9be74c18a","slug":"goals","fullItemName":"Goals"},{"id":"4a1ce510-f22c-5132-a344-31bd40831eac","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5d44fe-1deb-51e2-bb59-04ccc35710c7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4b396bfd-befc-5055-a086-61c9628b6042","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"db6fe095-36c1-5949-87a9-e1c049f58234","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e5c4d5c6-ed37-5a97-a1ef-874a072dd190","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ab09ceb7-2cc4-57c7-a6ec-887e4df64336","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"25bf5688-a664-56d4-b6cd-077f06dc4be5","slug":"definition","fullItemName":"Definition"},{"id":"d85a2164-704c-52e3-b5f8-2170aa56ead6","slug":"causes","fullItemName":"Causes"},{"id":"06951cf4-8eb9-5dc4-89be-8f9d5c691a2c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e6f67db6-38d0-57cd-a3fa-15d68e43e3a3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"26204955-9976-5215-8ba5-fb73d7b50a95","slug":"complications","fullItemName":"Complications"}]},{"id":"41a2bada-cc7d-5a86-9495-82d662957b3a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d4b618cd-66fe-50a0-a686-99007ef42fc3","slug":"when-to-suspect-mrsa","fullItemName":"When to suspect MRSA"},{"id":"8c893fa3-9e5e-5db1-87f3-370e7e9afd70","slug":"assessment","fullItemName":"Assessment"},{"id":"01c6eee3-9b6f-5c05-8f49-c30279e03ddf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4d78ace1-1174-5c0f-b2e6-c74c8a51847a","fullItemName":"Management","slug":"management","subChapters":[{"id":"ddb73bdb-86dd-524d-92b2-f92b0ca957a0","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"a6c4d845-e78e-5116-b950-e78374132545","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9eb97cdf-d2a2-5018-9667-43dbca0cb266","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ef38f185-0695-523f-bf60-bd75e123a75e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aea98085-ac9a-5b4c-a54b-a8857e1055e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"795e0448-4ce8-5b2a-8a85-3aa1ecac9c40","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"834f64f0-6780-5945-914d-8f8a0d4e8dfe","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7c573460-655d-5212-8d3c-fb5758d25c43","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"43afc1fb-06c4-5ec8-9051-d49b5156cfc6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9537a389-c41a-5355-ac9c-9c56bba48a35","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}